Immunosuppression by δ-opioid antagonist naltrindole: δ- and triple μ/δ/κ/-opioid receptor knockout mice reveal a nonopioid activity

Journal of Pharmacology and Experimental Therapeutics

Volumn 298, Issue 3, 2001, Pages 1193-1198

  Gavériaux Ruff, Claire ^a   Filliol, Dominique ^a   Simonin, Frédéric ^a   Matthes, Hans W D ^a   Kieffer, Brigitte L ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

7 BENZYLIDENENALTREXONE; CYCLOSPORIN A; CYTOKINE; DELTA OPIATE RECEPTOR; INTERLEUKIN 2; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALTRIBEN; NALTRINDOLE; OPIATE ANTAGONIST;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ACTIVITY; GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; KNOCKOUT MOUSE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; BENZYLIDENE COMPOUNDS; CELL DIVISION; CONCANAVALIN A; DIPEPTIDES; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTES; MICE; MICE, KNOCKOUT; NALTREXONE; NARCOTIC ANTAGONISTS; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, SIGMA; T-LYMPHOCYTES; TETRAHYDROISOQUINOLINES;

EID: 0034889718     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Immunosuppression by delta opioid receptor antagonist
2. New δ-opioid antagonists as pharmacological probes
3. Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2
4. Overview of transplantation immunology and the pharmacotherapy of adult solid organ transplant recipients: Focus on immunosuppression
5. Non-peptide delta opioid agonists and antagonists
6. Opioid modulation of immune responses: Effects on phagocyte and lymphoid cell populations
7. δ- and μ-opioid receptor-deficient mice exhibit opposing alterations of emotional responses
8. Abolition of morphine-immunosuppression in mice lacking the μ-opioid receptor gene
9. A comparative study of immunomodulation produced by in vitro exposure to delta opioid receptor agonist peptides
10. Suppression of immune function by non-peptidic delta opioid receptor antagonists
11. In vitro exposure to peptidic delta opioid receptor antagonists results in limited immunosuppression
12. Molecular aspects of opioid receptors
13. Opioids: First lessons from knock-out mice
14. Immunomodulatory action of class μ, δ, and κ-opioid receptor agonists in mice
15. Design of δ-opioid peptide antagonists for emerging drug applications
16. Naltrexone suppresses the rejection of cardiac tissue transplantation
17. The d1-opioid receptor antagonist, 7-benzylspiroindanylnaltrexone, prolongs renal allograft survival in a rat model
18. Clinical Pharmacology and adverse effects
19. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid receptor gene
20. Delta opioid receptor expression is induced by concanavalin A in CD4+ T-cells
21. Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist
22. 1 opioid receptor antagonist: 7-Benzylidenenaltrexone (BNTX)
23. Pharmacological characterization of the cloned κ-, δ-, and μ-opioid receptors
24. Endogenous opioids modulate allograft rejection time in mice: Possible relation with Th1/Th2 cytokines
25. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivates with extraordinary δ opioid antagonist activity
26. Antiproliferative effects of δ opioids on highly purified CD4+ and CD8+ murine T cells
27. Evidence for opioid receptors on cells involved in host defense and the immune system
28. Detection of basal levels and induction of delta opioid receptor mRNA in murine splenocytes
29. Analysis of [3H] bremazocine binding in single and combinatorial opioid receptor knock-out mice
30. Disruption of the κ-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective κ-agonist U-50,488H and attenuates morphine withdrawal
31. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: Evidence for delta opioid receptor subtypes
32. Agonist and antagonist activities of ligands from naltrexone and oxymorphone
33. Endogenous opiates
34. Opioids, reward and addiction: An encounter of biology, psychology and medicine
35. Opioid receptor types and subtypes: The δ receptor as a model